advertising
-
1
Driver VR, Fabbi M, Lavery LA, et al.: The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 52(suppl): 17S, 2010.
-
2
Jeffocoate WJ, Harding KG: Diabetic foot ulcers. Lancet 361: 1545, 2003.
-
3
Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, et al.: The global burden of diabetic foot disease. Lancet 366: 1719, 2005.
-
4
Connor H: Some historical aspects of diabetic foot disease. Diabetes Metab Res Rev 24(suppl 1): S7, 2008.
-
5
Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA 293: 217, 2005.
-
6
Zhang P, Lu J, Jing Y, et al.: Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med 49: 106, 2017.
-
7
Walsh JW, Hoffstad OJ, Sullivan MO, et al.: Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med 33: 1493, 2016.
-
8
Geiss LS, Li Y, Hora I, et al.: Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population. Diabetes Care 42: 50, 2019.
-
9
Robbins JM, Strauss G, Aron D, et al.: Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? JAPMA 98: 489, 2008.
-
10
Moulik PK, Mtonga R, Gill GV: Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26: 491, 2003.
-
11
Kristensen MT, Holm G, Kirketerp-Moller K, et al.: Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do? Interact Cardiovasc Thorac Surg 14: 543, 2012.
-
12
Hoffstad O, Mitra N, Walsh J, et al.: Diabetes, lower-extremity amputation, and death. Diabetes Care 38: 1852, 2015.
-
13
Brown BJ, Crone CG, Attinger CE: Amputation in the diabetic to maximize function. Semin Vasc Surg 25: 115, 2012.
-
14
Evans KK, Attinger CE, Al-Attar A, et al.: The importance of limb preservation in the diabetic population. J Diabetes Complications 25: 227, 2011.
-
15
Vogel TR, Petroski GF, Kruse RL: Impact of amputation level and comorbidities on functional status of nursing home residents after lower extremity amputation. J Vasc Surg 59: 1323, 2014.
-
16
Serizawa F, Sasaki S, Fujishima S, et al.: Mortality rates and walking ability transition after lower limb major amputation in hemodialysis patients. J Vasc Surg 64: 1018, 2016.
-
17
Wukich DK, Ahn J, Raspovic KM, et al.: Comparison of transtibial amputations in diabetic patients with and without end-stage renal disease. Foot Ankle Int 38: 388, 2017.
-
18
Peters EJ, Childs MR, Wunderlich RP, et al.: Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care 24: 1799, 2001.
-
19
Lefebvre KM, Metraux S: Disparities in level of amputation among minorities: implications for improved preventative care. J Natl Med Assoc 101: 649, 2009.
-
20
Lefebvre KM, Lavery LA: Disparities in amputations in minorities. Clin Orthop Relat Res 469: 1941, 2011.
-
21
Agency for Healthcare Research and Quality: Overview of the National (Nationwide) Inpatient Sample (NIS). Available at: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Published 2019. Accessed February 23, 2019.
-
22
HCUP National Inpatient Sample (NIS): 2012-2014. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, Rockville, MD, 2014.
-
23
Sohn MW, Budiman-Mak E, Stuck RM, et al.: Diagnostic accuracy of existing methods for identifying diabetic foot ulcers from inpatient and outpatient datasets. J Foot Ankle Res 3: 27, 2010.
-
24
Fincke BG, Miller DR, Turpin R: A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database. BMC Health Serv Res 10: 192, 2010.
-
25
Nowygrod R, Egorova N, Greco G, et al.: Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 43: 205, 2006.
-
26
Elixhauser A, Steiner C, Harris DR, et al.: Comorbidity measures for use with administrative data. Med Care 36: 8, 1998.
-
27
Agency for Health Research and Quality: Population denominator data for use with HCUP databases. Available at: https://www.hcup-us.ahrq.gov/reports/methods/2017-04.pdf.Published2016. Accessed April 24, 2016.
-
28
Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century, National Academy Press, Washington, DC, 2001.
-
29
Arya S, Binney Z, Khakharia A, et al.: Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease. J Am Heart Assoc 7: e007425, 2018.
-
30
Eslami MH, Zayaruzny M, Fitzgerald GA: The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg 45: 55, 2007.
-
31
Kim PJ, Attinger CE, Steinberg JS, et al.: Building a multidisciplinary hospital-based wound care center: nuts and bolts. Plast Reconstr Surg 138(suppl): 241S, 2016.
-
32
Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13: 513, 1990.
-
33
Kim PJ, Evans KK, Steinberg JS, et al.: Critical elements to building an effective wound care center. J Vasc Surg 57: 1703, 2013.
-
34
Sinkin JC, Reilly M, Cralley A, et al.: Multidisciplinary approach to soft-tissue reconstruction of the diabetic Charcot foot. Plast Reconstr Surg 135: 611, 2015.
-
35
Driver VR, Fabbi M, Lavery LA, et al.: The costs of diabetic foot: the economic case for the limb salvage team. JAPMA 100: 335, 2010.
-
36
Attinger CE, Brown BJ: Amputation and ambulation in diabetic patients: function is the goal. Diabetes Metab Res Rev 28(suppl 1): 93, 2012.
-
37
Wukich DK, Raspovic KM: What role does function play in deciding on limb salvage versus amputation in patients with diabetes? Plast Reconstr Surg 138(suppl): 188S, 2016.
-
38
Souza JM, Cheesborough JE, Ko JH, et al.: Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop Relat Res 472: 2984, 2014.
-
39
Pinzur MS, Gottschalk F, Pinto MA, et al.: Controversies in lower extremity amputation. Instr Course Lect 57: 663, 2008.
-
40
Adams BE, Edlinger JP, Ritterman Weintraub ML, et al.: Three-year morbidity and mortality rates after nontraumatic transmetatarsal amputation. J Foot Ankle Surg 57: 967, 2018.
-
41
Pollard J, Hamilton GA, Rush SM, et al.: Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases. J Foot Ankle Surg 45: 91, 2006.
-
42
Tan MNA, Lo ZJ, Lee SH, et al.: Review of transmetatarsal amputations in the management of peripheral arterial disease in an Asian population. Ann Vasc Dis 11: 210, 2018.
-
43
Thomas SR, Perkins JM, Magee TR, et al.: Transmetatarsal amputation: an 8-year experience. Ann R Coll Surg Engl 83: 164, 2001.
-
44
Suckow BD, Goodney PP, Cambria RA, et al.: Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg 26: 67, 2012.
-
45
Waters RL, Perry J, Antonelli D, et al.: Energy cost of walking of amputees: the influence of level of amputation. J Bone Joint Surg Am 58: 42, 1976.
-
46
Margolis DJ, Hoffstad O, Nafash J, et al.: Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care 34: 2363, 2011.
A Focus on Amputation Level: Factors Preventing Length Preservation in the National Inpatient Sample
Search for other papers by Kenneth L. Fan in
Current site
Google Scholar
PubMed
Search for other papers by Jenna C. Bekeny in
Current site
Google Scholar
PubMed
Search for other papers by Christopher J. Kennedy in
Current site
Google Scholar
PubMed
Search for other papers by Elizabeth G. Zolper in
Current site
Google Scholar
PubMed
Search for other papers by John S. Steinberg in
Current site
Google Scholar
PubMed
Search for other papers by Christopher E. Attinger in
Current site
Google Scholar
PubMed
Search for other papers by Karen K. Evans in
Current site
Google Scholar
PubMed
MedStar Health Research Institute, Hyattsville, MD.
Search for other papers by Derek DeLia in
Current site
Google Scholar
PubMed
Background: Diabetic lower-extremity disease is the primary driver of mortality in patients with diabetes. Amputations at the forefoot or ankle preserve limb length, increase function, and, ultimately, reduce deconditioning and mortality compared with higher-level amputations, such as below-the-knee amputations (BKAs). We sought to identify risk factors associated with amputation level to understand barriers to length-preserving amputations (LPAs).
Methods: Diabetic lower-extremity admissions were extracted from the 2012-2014 National Inpatient Survey using ICD-9-CM diagnosis codes. The main outcome was a two-level variable consisting of LPAs (transmetatarsal, Syme, and Chopart) versus BKAs. Logistic regression analysis was used to determine contributions of patient- and hospital-level factors to likelihood of undergoing LPA versus BKA.
Results: The study cohort represented 110,355 admissions nationally: 42,375 LPAs and 67,980 BKAs. The population was predominantly white (56.85%), older than 50 years (82.55%), and male (70.38%). On multivariate analysis, living in an urban area (relative risk ratio [RRR] = 1.48; P < .0001) and having vascular intervention in the same hospital stay (RRR = 2.96; P < .0001) were predictive of LPA. Patients from rural locations but treated in urban centers were more likely to receive BKA. Minorities were more likely to present with severe disease, limiting delivery of LPAs. A high Elixhauser comorbidity score was related to BKA receipt.
Conclusions: This study identifies delivery biases in amputation level for patients without access to large, urban hospitals. Rural patients seeking care in these centers are more likely to receive higher-level amputations. Further examination is required to determine whether earlier referral to multidisciplinary centers is more effective at reducing BKA rates versus satellite centers in rural localities.
advertising
